
ML390
CAS No. 2029049-79-2
ML390( —— )
Catalog No. M22425 CAS No. 2029049-79-2
ML390 exerts its potent differentiation effect on multiple leukemia models.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 50 | In Stock |
![]() ![]() |
10MG | 65 | In Stock |
![]() ![]() |
25MG | 110 | In Stock |
![]() ![]() |
50MG | 170 | In Stock |
![]() ![]() |
100MG | 302 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameML390
-
NoteResearch use only, not for human use.
-
Brief DescriptionML390 exerts its potent differentiation effect on multiple leukemia models.
-
DescriptionML390 exerts its potent differentiation effect on multiple leukemia models.
-
In VitroML390 is active with an ED50 of ~2 μM in murine and human AML cell lines. In vitro, treatment of Lys-GFP-ER-HoxA9 cells with ML390 for 48 hr inhibits DHODH activity, leading to the dramatic (>500-fold) accumulation of the upstream metabolite DHO and the depletion of uridine and other downstream metabolites.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2029049-79-2
-
Formula Weight406.4
-
Molecular FormulaC21H21F3N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:27 mg/mL (66.44 mM)
-
SMILESFC(F)(F)Oc1ccc(cc1)C(=O)NCCC(=O)N[C@@H]1CCCc2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sykes DB et al. Discovering Small Molecules that Overcome Differentiation Arrest in Acute Myeloid Leukemia. National Center for Biotechnology Information (US); 2010-2013 Dec 15.
molnova catalog



related products
-
Imisopasem manganese
A small-molecule superoxide dismutase (SOD) mimetic that converts superoxide to hydrogen peroxide and molecular oxygen.
-
4-hydroxy-3-methylbe...
4-Hydroxy-3-methylbenzoic acid is a normal organic acid identified in urine specimens from a healthy population.
-
Azido-PEG4-azide
Azido-PEG4-azide is a PEG-based PROTAC linker that can be used to synthesize PROTACs.